Delivery Order SPE2DB24D8001-SPE2DB24FKYXB

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $1,312.08 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 with the DLA Troop Support Medical under the ECAT Generation V Program, which allows the company to provide a wide range of pharmaceutical products,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,378.16 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT Generation V Program, which has a potential value of $999,999,999.00 and a performance period...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,232.70 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. This contract is for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription pharmaceutical product. The contract has an ultimate completion date of August 8, 2024 and was awarded on August 7, 2024. Dakota Drug, Inc. has a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,760.74 firm fixed-price contract is for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. This award is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $1,417.02, has an ultimate completion date of March 26, 2025. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00,...
The Defense Logistics Agency (DLA) awarded a $1,340.67 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger $999,999,999.00 single-award Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $4,418.80 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This contract has an ultimate completion date of November 8, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price of $2,798.42 and a performance period through March 6, 2025. Dakota Drug, Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,608.64 contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on June 6, 2024. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT Generation V Program, which allows...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML medical supplies. The contract has a ceiling value of $1,730.35 and a period of performance through December 26, 2023. This award is under Dakota Drug's existing Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows the company to provide a...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB24FKYXB
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,661.99 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. This delivery order falls under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract does not have a set-aside designation.

Generated 11/12/24, 9:03 AM